Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1999
Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre studyR Cocchi, E Degli Esposti, A Fabbri, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 2001
A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosisR Zivadinov, J Sepcic, D Nasuelli, et al.Bioorganic & Medicinal Chemistry|July 5, 2011
Human HDAC isoform selectivity achieved via exploitation of the acetate release channel with structurally unique small molecule inhibitorsLewis Whitehead, Markus R Dobler, Branko Radetich, et al.Bioorganic & Medicinal Chemistry Letters|November 1, 2003
N-arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin BPaul D Greenspan, Kirk L Clark, Scott D Cowen, et al.Bioorganic & Medicinal Chemistry Letters|September 23, 2011
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13Ruben A Tommasi, Sven Weiler, Leslie W McQuire, et al.Functional Neurology|April 11, 2018
Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary dataA Pascarella, S Fiorenza, O Masotta, et al.Journal of Medicinal Chemistry|August 28, 1998
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide classS R Turner, J W Strohbach, R A Tommasi, et al.Journal of Medicinal Chemistry|November 8, 1996
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitorsS Thaisrivongs, D L Romero, R A Tommasi, et al.Bioorganic & Medicinal Chemistry|November 7, 2020
N-Hydroxyformamide LpxC inhibitors, their in vivo efficacy in a mouse Escherichia coli infection model, and their safety in a rat hemodynamic assayTakeru Furuya, Adam B Shapiro, Janelle Comita-Prevoir, et al.Journal of Medicinal Chemistry|December 14, 2001
Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug designP D Greenspan, K L Clark, R A Tommasi, et al.Pageof 4